Pharmafile Logo

Rare Disease Day 2019

February 28, 2019 | Infographic, Rare Disease Day, rare disease 

Today is #RareDiseaseDay and is an opportunity to highlight some truly unbelievable/frightening statistics around rare diseases.

Did you know, for example, that over 3.5 million people in the UK suffer from a rare disease or that 95% of rare diseases don’t have an approved treatment drug and yet they impact more people than cancer and AIDs combined?

This is why it is so important to raise awareness of the impact of rare diseases on patients’ lives. We have designed this infographic to highlight some of these facts and figures, please do share it to help raise awareness.

- PMLiVE

This content was provided by Cuttsy + Cuttsy

Documents for download:

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People

Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.

Cuttsy+Cuttsy awarded Gold EcoVadis sustainability rating

Cuttsy+Cuttsy proudly announces their Gold Medal achievement from EcoVadis for 2024, placing them among the top 5% of companies assessed and within the 97th percentile, a testament to their unwavering...

Age is not just a number when it comes to clinical trials

In this blog we look at the critical underrepresentation of older adults in clinical trials, emphasising the need for inclusive trial designs and targeted strategies to ensure safe and effective...

How to boost clinical trial access and make patients health-empowered

Clinical research is becoming more patient-centric, but there's still more that needs to be done to make clinical trials available to everyone. This could include wider participation.

Closing the loop: Why clinical trial results matter to participants

Discover why sharing clinical trial results with participants is crucial for respect, informed health decisions, and fostering strong researcher-participant partnerships.

Unveiling the truth: A journey into women’s representation in clinical trials

We explore the historical exclusion of women from clinical trials, its consequences on medical research and treatment efficacy and the ongoing efforts to ensure their representation.

Clarity in clinical trials

Discover how transparent, empathetic communication and health literacy principles can empower patients and enhance engagement in clinical trials, transforming participants into active partners in their healthcare journey.

Caring for patients’ mental health in clinical trials

We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.

Driving equitable healthcare: The role of DE&I in clinical trials

Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...

Empowering patients through more accessible clinical trial information

Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...